schliessen

Filtern

 

Bibliotheken

Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.

PURPOSEPatients with myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, have a propensity to develop acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs). Using population-based data from Sweden, we assessed the role o... Full description

Journal Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology June 10, 2011, Vol.29(17), pp.2410-2415
Main Author: Björkholm, Magnus
Other Authors: Derolf, Asa R , Hultcrantz, Malin , Kristinsson, Sigurdur Y , Ekstrand, Charlotta , Goldin, Lynn R , Andreasson, Björn , Birgegård, Gunnar , Linder, Olle , Malm, Claes , Markevärn, Berit , Nilsson, Lars , Samuelsson, Jan , Granath, Fredrik , Landgren, Ola
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1527-7755 ; DOI: 10.1200/JCO.2011.34.7542
Link: http://search.proquest.com/docview/871385672/?pq-origsite=primo
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: proquest871385672
title: Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
format: Article
creator:
  • Björkholm, Magnus
  • Derolf, Asa R
  • Hultcrantz, Malin
  • Kristinsson, Sigurdur Y
  • Ekstrand, Charlotta
  • Goldin, Lynn R
  • Andreasson, Björn
  • Birgegård, Gunnar
  • Linder, Olle
  • Malm, Claes
  • Markevärn, Berit
  • Nilsson, Lars
  • Samuelsson, Jan
  • Granath, Fredrik
  • Landgren, Ola
subjects:
  • Adult–Adverse Effects
  • Aged–Etiology
  • Antineoplastic Agents, Alkylating–Mortality
  • Case-Control Studies–Etiology
  • Female–Mortality
  • Humans–Adverse Effects
  • Leukemia, Myeloid, Acute–Complications
  • Leukocyte Count–Therapy
  • Logistic Models–Complications
  • Male–Therapy
  • Middle Aged–Complications
  • Myelodysplastic Syndromes–Therapy
  • Phosphorus Radioisotopes–Therapy
  • Polycythemia Vera–Therapy
  • Primary Myelofibrosis–Therapy
  • Risk Factors–Therapy
  • Thrombocythemia, Essential–Therapy
  • Antineoplastic Agents, Alkylating
  • Phosphorus Radioisotopes
ispartof: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, June 10, 2011, Vol.29(17), pp.2410-2415
description: PURPOSEPatients with myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, have a propensity to develop acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs). Using population-based data from Sweden, we assessed the role of...
language: eng
source:
identifier: E-ISSN: 1527-7755 ; DOI: 10.1200/JCO.2011.34.7542
fulltext: fulltext
issn:
  • 15277755
  • 1527-7755
url: Link


@attributes
ID731046712
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid871385672
sourceidproquest
recordidTN_proquest871385672
sourcesystemPC
pqid871385672
display
typearticle
titleTreatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
creatorBjörkholm, Magnus ; Derolf, Asa R ; Hultcrantz, Malin ; Kristinsson, Sigurdur Y ; Ekstrand, Charlotta ; Goldin, Lynn R ; Andreasson, Björn ; Birgegård, Gunnar ; Linder, Olle ; Malm, Claes ; Markevärn, Berit ; Nilsson, Lars ; Samuelsson, Jan ; Granath, Fredrik ; Landgren, Ola
contributorBjörkholm, Magnus (correspondence author) ; Björkholm, Magnus (record owner)
ispartofJournal of clinical oncology : official journal of the American Society of Clinical Oncology, June 10, 2011, Vol.29(17), pp.2410-2415
identifierE-ISSN: 1527-7755 ; DOI: 10.1200/JCO.2011.34.7542
subjectAdult–Adverse Effects ; Aged–Etiology ; Antineoplastic Agents, Alkylating–Mortality ; Case-Control Studies–Etiology ; Female–Mortality ; Humans–Adverse Effects ; Leukemia, Myeloid, Acute–Complications ; Leukocyte Count–Therapy ; Logistic Models–Complications ; Male–Therapy ; Middle Aged–Complications ; Myelodysplastic Syndromes–Therapy ; Phosphorus Radioisotopes–Therapy ; Polycythemia Vera–Therapy ; Primary Myelofibrosis–Therapy ; Risk Factors–Therapy ; Thrombocythemia, Essential–Therapy ; Antineoplastic Agents, Alkylating ; Phosphorus Radioisotopes
descriptionPURPOSEPatients with myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, have a propensity to develop acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs). Using population-based data from Sweden, we assessed the role of...
languageeng
source
version4
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://search.proquest.com/docview/871385672/?pq-origsite=primo$$EView_record_in_ProQuest_(subscribers_only)
search
creatorcontrib
0Björkholm, Magnus
1Derolf, Asa R
2Hultcrantz, Malin
3Kristinsson, Sigurdur Y
4Ekstrand, Charlotta
5Goldin, Lynn R
6Andreasson, Björn
7Birgegård, Gunnar
8Linder, Olle
9Malm, Claes
10Markevärn, Berit
11Nilsson, Lars
12Samuelsson, Jan
13Granath, Fredrik
14Landgren, Ola
titleTreatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
descriptionPURPOSEPatients with myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, have a propensity to develop acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs). Using population-based data from Sweden, we assessed the role of...
subject
0Adult–Adverse Effects
1Aged–Etiology
2Antineoplastic Agents, Alkylating–Mortality
3Case-Control Studies–Etiology
4Female–Mortality
5Humans–Adverse Effects
6Leukemia, Myeloid, Acute–Complications
7Leukocyte Count–Therapy
8Logistic Models–Complications
9Male–Therapy
10Middle Aged–Complications...
general
0English
110.1200/JCO.2011.34.7542
2MEDLINE (ProQuest)
3ProQuest Biological Science Collection
4ProQuest Natural Science Collection
5ProQuest SciTech Collection
6Biological Science Database
7Natural Science Collection
8SciTech Premium Collection
9Health Research Premium Collection
10Health Research Premium Collection (Alumni edition)
11Biological Science Index (ProQuest)
sourceidproquest
recordidproquest871385672
issn
015277755
11527-7755
rsrctypearticle
creationdate2011
addtitleJournal of clinical oncology : official journal of the American Society of Clinical Oncology
searchscope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
scope
01007527
11007944
21009130
310000004
410000038
510000050
610000120
710000159
810000238
910000253
1010000260
1110000270
1210000271
1310000302
1410000350
15proquest
lsr43
01007527false
11007944false
21009130false
310000004false
410000038false
510000050false
610000120false
710000159false
810000238false
910000253false
1010000260false
1110000270false
1210000271false
1310000302false
1410000350false
contributorBjörkholm, Magnus
startdate20110610
enddate20110610
citationpf 2410 pt 2415 vol 29 issue 17
lsr30VSR-Enriched:[pqid, issn]
sort
titleTreatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
authorBjörkholm, Magnus ; Derolf, Asa R ; Hultcrantz, Malin ; Kristinsson, Sigurdur Y ; Ekstrand, Charlotta ; Goldin, Lynn R ; Andreasson, Björn ; Birgegård, Gunnar ; Linder, Olle ; Malm, Claes ; Markevärn, Berit ; Nilsson, Lars ; Samuelsson, Jan ; Granath, Fredrik ; Landgren, Ola
creationdate20110610
lso0120110610
facets
frbrgroupid7682759302793539156
frbrtype5
newrecords20181218
languageeng
creationdate2011
topic
0Adult–Adverse Effects
1Aged–Etiology
2Antineoplastic Agents, Alkylating–Mortality
3Case-Control Studies–Etiology
4Female–Mortality
5Humans–Adverse Effects
6Leukemia, Myeloid, Acute–Complications
7Leukocyte Count–Therapy
8Logistic Models–Complications
9Male–Therapy
10Middle Aged–Complications...
collection
0MEDLINE (ProQuest)
1ProQuest Biological Science Collection
2ProQuest Natural Science Collection
3ProQuest SciTech Collection
4Biological Science Database
5Natural Science Collection
6SciTech Premium Collection
7Health Research Premium Collection
8Health Research Premium Collection (Alumni edition)
9Biological Science Index (ProQuest)
prefilterarticles
rsrctypearticles
creatorcontrib
0Björkholm, Magnus
1Derolf, Asa R
2Hultcrantz, Malin
3Kristinsson, Sigurdur Y
4Ekstrand, Charlotta
5Goldin, Lynn R
6Andreasson, Björn
7Birgegård, Gunnar
8Linder, Olle
9Malm, Claes
10Markevärn, Berit
11Nilsson, Lars
12Samuelsson, Jan
13Granath, Fredrik
14Landgren, Ola
jtitleJournal of clinical oncology : official journal of the American Society of Clinical Oncology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Björkholm
1Derolf
2Hultcrantz
3Kristinsson
4Ekstrand
5Goldin
6Andreasson
7Birgegård
8Linder
9Malm
10Markevärn
11Nilsson
12Samuelsson
13Granath
14Landgren
aufirst
0Magnus
1Asa R
2Malin
3Sigurdur Y
4Charlotta
5Lynn R
6Björn
7Gunnar
8Olle
9Claes
10Berit
11Lars
12Jan
13Fredrik
14Ola
au
0Björkholm, Magnus
1Derolf, Asa R
2Hultcrantz, Malin
3Kristinsson, Sigurdur Y
4Ekstrand, Charlotta
5Goldin, Lynn R
6Andreasson, Björn
7Birgegård, Gunnar
8Linder, Olle
9Malm, Claes
10Markevärn, Berit
11Nilsson, Lars
12Samuelsson, Jan
13Granath, Fredrik
14Landgren, Ola
addauBjörkholm, Magnus
atitleTreatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
jtitleJournal of clinical oncology : official journal of the American Society of Clinical Oncology
risdate20110610
volume29
issue17
spage2410
epage2415
pages2410-2415
eissn1527-7755
formatjournal
genrearticle
ristypeJOUR
abstractPURPOSEPatients with myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis, have a propensity to develop acute myeloid leukemia (AML) and myelodysplastic syndromes (MDSs). Using population-based data from Sweden, we assessed the role of...
doi10.1200/JCO.2011.34.7542
urlhttp://search.proquest.com/docview/871385672/
issn0732183X
date2011-06-10